Cargando…

Nabilone administration in refractory chronic diarrhea: a case series

BACKGROUND: Daily cannabis assumption is currently associated with several physical and mental health problems, however in the past it was prescribed for a multitude of symptoms, including vomiting, abdominal pain and diarrhea. Through the years, the endocannabinoid system has been recognized in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellesi, Lanfranco, Verga, Maria Chiara, De Maria, Nicola, Villa, Erica, Pini, Luigi Alberto, Guerzoni, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/ https://www.ncbi.nlm.nih.gov/pubmed/31238887 http://dx.doi.org/10.1186/s12876-019-1024-y

Ejemplares similares

Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
por: Pellesi, Lanfranco, et al.
Publicado: (2017)

Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
por: Guerzoni, Simona, et al.
Publicado: (2016)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
por: Lo Castro, Flavia, et al.
Publicado: (2022)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?
por: Pellesi, Lanfranco
Publicado: (2023)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
por: Ware1, Mark A, et al.
Publicado: (2008)

Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study
por: Stefani, Alessandro, et al.
Publicado: (2020)

The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials
por: Bajtel, Ákos, et al.
Publicado: (2022)

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
por: Ahmedzai, S., et al.
Publicado: (1983)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

PM501. Acute Effects of Nicotine and Nabilone on the Mismatch Negativity: A Combined Time-Frequency and Event-Related Potential Study
por: Nelson, Renee, et al.
Publicado: (2016)

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Nabilone treatment for severe behavioral problems in adults with intellectual and developmental disabilities: Protocol for a phase I open-label clinical trial
por: Lin, Hsiang-Yuan, et al.
Publicado: (2023)

Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
por: Sacco, Simona, et al.
Publicado: (2019)

Serum protein changes in a rat model of chronic pain show a correlation between animal and humans
por: Bellei, Elisa, et al.
Publicado: (2017)

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
por: Ruthirakuhan, Myuri T., et al.
Publicado: (2019)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants
por: Bacchelli, Elena, et al.
Publicado: (2016)

A Rare Cause of Refractory Chronic Diarrhea and Cachexia: A Case Report
por: HADJ KACEM, Faten, et al.
Publicado: (2020)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
por: Patel, Maitri, et al.
Publicado: (2022)

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2015)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Relevance of analgesic abuse in the maintenance of chronic headaches
por: Pini, Luigi Alberto, et al.
Publicado: (2000)

Chronic diarrhea
por: Gryboski, Joyce D.
Publicado: (1979)

Chronic Diarrhea
Publicado: (1882)

One-year infliximab administration for the treatment of chronic refractory pouchitis
por: Viazis, Nikos, et al.
Publicado: (2011)

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6ilpr5ti3tvsf43782ge6hs5qg